Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Jan 22;286(6361):289–292. doi: 10.1136/bmj.286.6361.289

Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?

G R Venning
PMCID: PMC1546494  PMID: 6218859

Abstract

The process of discovery of 18 important adverse drug reactions was reviewed. For each adverse reaction the dates were noted of the report which first alerted the medical profession to the suspected reaction, the report which resulted in verification of causality beyond reasonable doubt, and the first regulatory action or warning to the medical profession in Britain by the Committee on the Safety of Medicines.

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYCE J., FAWCETT J. W., NOALL E. W. Coronary thrombosis and Conovide. Lancet. 1963 Jan 12;1(7272):111–111. doi: 10.1016/s0140-6736(63)91117-6. [DOI] [PubMed] [Google Scholar]
  2. BURNAP T. K., GALLA S. J., VANDAM L. D. Anesthetic, circulatory and respiratory effects of fluothane. Anesthesiology. 1958 May-Jun;19(3):307–320. doi: 10.1097/00000542-195805000-00001. [DOI] [PubMed] [Google Scholar]
  3. Beral V., Colwell L. Randomised trial of high doses of stilboestrol and ethisterone therapy in pregnancy: long-term follow-up of the children. J Epidemiol Community Health. 1981 Sep;35(3):155–160. doi: 10.1136/jech.35.3.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown P., Baddeley H., Read A. E., Davies J. D., McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet. 1974 Dec 21;2(7895):1477–1481. doi: 10.1016/s0140-6736(74)90218-9. [DOI] [PubMed] [Google Scholar]
  5. FINNEY D. J. THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE. J Chronic Dis. 1965 Jan;18:77–98. doi: 10.1016/0021-9681(65)90054-8. [DOI] [PubMed] [Google Scholar]
  6. Felix R. H., Comaish J. S. The value of patch and other skin tests in drug eruptions. Lancet. 1974 May 25;1(7865):1017–1019. doi: 10.1016/s0140-6736(74)90417-6. [DOI] [PubMed] [Google Scholar]
  7. Felix R. H., Ive F. A., Dahl M. G. Cutaneous and ocular reactions to practolol. Br Med J. 1974 Nov 9;4(5940):321–324. doi: 10.1136/bmj.4.5940.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GRAHAM J. R. METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS. N Engl J Med. 1964 Jan 9;270:67–72. doi: 10.1056/NEJM196401092700202. [DOI] [PubMed] [Google Scholar]
  9. Graham J. R., Suby H. I., LeCompte P. R., Sadowsky N. L. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med. 1966 Feb 17;274(7):359–368. doi: 10.1056/NEJM196602172740701. [DOI] [PubMed] [Google Scholar]
  10. Herbst A. L., Kurman R. J., Scully R. E., Poskanzer D. C. Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21;287(25):1259–1264. doi: 10.1056/NEJM197212212872501. [DOI] [PubMed] [Google Scholar]
  11. Herbst A. L., Scully R. E. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer. 1970 Apr;25(4):745–757. doi: 10.1002/1097-0142(197004)25:4<745::aid-cncr2820250402>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  12. Herbst A. L., Ulfelder H., Poskanzer D. C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 Apr 15;284(15):878–881. doi: 10.1056/NEJM197104222841604. [DOI] [PubMed] [Google Scholar]
  13. Inman W. H., Adelstein A. M. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet. 1969 Aug 9;2(7615):279–285. doi: 10.1016/s0140-6736(69)90051-8. [DOI] [PubMed] [Google Scholar]
  14. Inman W. H., Vessey M. P. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br Med J. 1968 Apr 27;2(5599):193–199. doi: 10.1136/bmj.2.5599.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Inman W. H., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J. 1970 Apr 25;2(5703):203–209. doi: 10.1136/bmj.2.5703.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. KRAKOFF I. H., KARNOFSKY D. A., BURCHENAL J. H. Effects of large doses of chloramphenicol on human subjects. N Engl J Med. 1955 Jul 7;253(1):7–10. doi: 10.1056/NEJM195507072530102. [DOI] [PubMed] [Google Scholar]
  17. Klatskin G., Kimberg D. V. Recurrent hepatitis attributable to halothane sensitization in an anesthetist. N Engl J Med. 1969 Mar 6;280(10):515–522. doi: 10.1056/NEJM196903062801001. [DOI] [PubMed] [Google Scholar]
  18. LARSEN K., MOLLER C. E. A renal lesion caused by abuse of phenacetin. Acta Med Scand. 1959 May 20;164(1):53–71. doi: 10.1111/j.0954-6820.1959.tb00164.x. [DOI] [PubMed] [Google Scholar]
  19. Mann J. I., Inman W. H. Oral contraceptives and death from myocardial infarction. Br Med J. 1975 May 3;2(5965):245–248. doi: 10.1136/bmj.2.5965.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mann J. I., Vessey M. P., Thorogood M., Doll S. R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J. 1975 May 3;2(5965):241–245. doi: 10.1136/bmj.2.5965.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Marshall A. J., Baddeley H., Barritt D. W., Davies J. D., Lee R. E., Low-Beer T. S., Read A. E. Practolol peritonitis. A study of 16 cases and a survey of small bowel function in patients taking beta adrenergic blockers. Q J Med. 1977 Jan;46(181):135–149. [PubMed] [Google Scholar]
  22. Meade T. W. Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis. Br J Prev Soc Med. 1975 Sep;29(3):157–169. doi: 10.1136/jech.29.3.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. RICH M. L., RITTERHOFF R. J., HOFFMANN R. J. A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy. Ann Intern Med. 1950 Dec;33(6):1459–1467. doi: 10.7326/0003-4819-33-6-1459. [DOI] [PubMed] [Google Scholar]
  24. SCHWEINGRUBER R. Probleme der chronischen Vergiftung mit kombinierten Phenacetinpräparaten. Schweiz Med Wochenschr. 1955 Nov 26;85(48):1162–1166. [PubMed] [Google Scholar]
  25. Skegg D. C., Doll R. Frequency of eye complaints and rashes among patients receiving practolol and propranolol. Lancet. 1977 Sep 3;2(8036):475–478. doi: 10.1016/s0140-6736(77)91602-6. [DOI] [PubMed] [Google Scholar]
  26. Skegg D. C., Doll R. The case for recording events in clinical trials. Br Med J. 1977 Dec 10;2(6101):1523–1524. doi: 10.1136/bmj.2.6101.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Br Med J. 1968 Feb 10;1(5588):335–339. doi: 10.1136/bmj.1.5588.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Speizer F. E., Doll R., Heaf P., Strang L. B. Investigation into use of drugs preceding death from asthma. Br Med J. 1968 Feb 10;1(5588):339–343. doi: 10.1136/bmj.1.5588.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Stolley P. D. Asthma mortality. Why the United States was spared an epidemic of deaths due to asthma. Am Rev Respir Dis. 1972 Jun;105(6):883–890. doi: 10.1164/arrd.1972.105.6.883. [DOI] [PubMed] [Google Scholar]
  30. Trowell J., Peto R., Smith A. C. Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet. 1975 Apr 12;1(7911):821–824. [PubMed] [Google Scholar]
  31. Tsubaki T., Honma Y., Hoshi M. Neurological syndrome associated with clioquinol. Lancet. 1971 Apr 3;1(7701):696–697. doi: 10.1016/s0140-6736(71)92699-7. [DOI] [PubMed] [Google Scholar]
  32. VOLINI I. F., GREENSPAN I., EHRLICH L., GONNER J. A., FELSENFELD O., SCHWARTZ S. O. Hemopoietic changes during administration of chloramphenicol (chloromycetin). J Am Med Assoc. 1950 Apr 29;142(17):1333–1335. doi: 10.1001/jama.1950.02910350003002. [DOI] [PubMed] [Google Scholar]
  33. WALKER R. S., LINTON A. L. Phenethyldiguanide: a dangerous side-effect. Br Med J. 1959 Nov 14;2(5158):1005–1006. doi: 10.1136/bmj.2.5158.1005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wright P. Letter: Skin reactions to practolol. Br Med J. 1974 Jun 8;2(5918):560–560. doi: 10.1136/bmj.2.5918.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wright P. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J. 1975 Mar 15;1(5958):595–598. doi: 10.1136/bmj.1.5958.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Yao S. T., Gourmos C., Hobbs J. T. Detection of proximal-vein thrombosis by Doppler ultrasound flow-detection method. Lancet. 1972 Jan 1;1(7740):1–4. doi: 10.1016/s0140-6736(72)90001-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES